Compounded tirzepatide
Sold by JRNYS · every compounded tirzepatide record
The register has not established whether this program ships a vial, a pen, or another form. That is a gap in our record, not a statement about the company.
What you actually pay
Per month
$305
| Medication · Compounded Tirzepatide Microdose, cash pay, all-inclusive (not the brand-Mounjaro/Zepbound path above) | $216 |
|---|---|
| Required membership | $89 |
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Compounded Tirzepatide Microdose, cash pay, all-inclusive (not the brand-Mounjaro/Zepbound path above) “Physician-Backed Tirzepatide Microdose from $216/m” | Per month$216 | Charged today$216 |
We earn nothing from this link. JRNYS has no commercial arrangement with Treatment Registry, and its record here is kept to the same standard as every other.
History
One reading so far. A price history appears here after the next verification pass.
- September 2, 2026 — Entry added to the register
Sourcing and terms
| Prescriber | Asynchronous review |
|---|---|
| Cancellation | “Subscribers are required to give a notice of at least 7 days prior to their next billing cycle for cancellation of their subscription.” |
| Membership | Required. $89 per month. “Start for $89/month* *Does not include the cost of medication. ... Membership ranges from $89 per month to $169 per month depending on your level of 1-1 coach support. The base price includes your medical visits, daily monitoring, coaching & access to member exclusive content.” |
Not yet checked: pharmacy, states and consult fee.
Recorded from jrnys.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2, 2026 — Textbook membership trap: the headline '$89/month' figure repeated across the whole site is explicitly footnoted '*Does not include the cost of medication' and confirmed on product pages as a $89-$169/mo membership fee only. JRNYS sells brand-name GLP-1s (Ozempic, Mounjaro, Zepbound, Wegovy) via insurance navigation, for which the only price given is an insurance-capped '$25 per month after any deductible is met' (an insurance price, recorded separately per the brief's rule) — no cash price for the brand path is published. Separately, JRNYS also sells a 'Compounded Tirzepatide Microdose' product at a flat 'from $216/m' cash price, framed as inclusive ('Compounded medications are not FDA-approved... prepared by licensed pharmacies'); this is NOT the same product as the branded Mounjaro/Zepbound path and is recorded as its own entry. Also found a real self-contradiction: the Cancellation Policy page says 'your initial telehealth fee of $89 will not be refunded,' while the Terms & Conditions page says 'your initial telehealth fee of $35 will not be refunded' for the same fee — flagged, not resolved. No page stating served states was found. Footer legal text names a 'KINSYN' brand ('KINSYN provides clinician-guided wellness and metabolic health programs') alongside JRNYS, suggesting a shared backend across brands.
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.